1Fried MW. Therapy of chronic viral hepatitis. Med Clin Nor Amer, 1996, 5:957.
2Sherloek S, Dooley J. Chronic hepatitis,Disease of the liver and billary system.toth ed. London:Blackwell, 1997. 303.
3Di Bisceglie AM. Hepatitis C. Lancet,1998. 9099 : 351.
4Chow WC, Marcellin P, Erlinger S, et al. Re - treatment with imerferon alfa of patient with chronic hepatitis C. Hepatology, 1998,4:1144.
5Sherman KE, Goodman ZD. Ishak KG, et al. Combination therapy with thyrmosin alpha and interferon for the treatment of chronic hepatitis C interferon : a randomized, placebo- controlled double- blind trial.Hepatology,1998,4:1128.
6Farrel GC,Goldin RD, Bacon BR . Lymphoblastoid intederon alfa -nl improves the long - term response to 6-month course of treatment in chronic hepatitsi C compared with recombinant interferon alfa-2b:results of an internaional randomized controlled trial.Clinical Advisory Group for the Hepatitis C Comparative study Hepatology,1998,4:1121.
7Ouzan D,Opolon P,Valla D,et al.Comparison of high initial and fixed-dose regimens of interferon alfa-2a in chronic hepatitis C:a randomized controlled trial.J Viral Hepat,1998,1:53.
8Tanska K,Tanikawa K,Suzuki H,et al.Long-term evaluation of interferon therapy in hepatitis C virus-associated cirrhosis;does IFN prevent development of hepatocellular carcinoma?Oncol Rep,1998,1:205.
9Miyajima J,Tanikawa K,Suzuki H,et al.The incidence of hepatocellular carcinoma in patients with chronic hepatitis C after interferon treatment.Oncol Rep,1998,1:201.
10Weiland O,Loof L,Danielsson A,Treat ment response in chronic hepatits C,Content of virus in serum is decisive for the outcome.Lakartidningen,1998,95(1-2):40.
